684 related articles for article (PubMed ID: 22942876)
1. Therapeutic potential of metabotropic glutamate receptor modulators.
Hovelsø N; Sotty F; Montezinho LP; Pinheiro PS; Herrik KF; Mørk A
Curr Neuropharmacol; 2012 Mar; 10(1):12-48. PubMed ID: 22942876
[TBL] [Abstract][Full Text] [Related]
2. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Kew JN; Kemp JA
Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptors and neurodegenerative diseases.
Ribeiro FM; Vieira LB; Pires RG; Olmo RP; Ferguson SS
Pharmacol Res; 2017 Jan; 115():179-191. PubMed ID: 27872019
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.
Alexander GM; Godwin DW
Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741
[TBL] [Abstract][Full Text] [Related]
5. Group I metabotropic glutamate receptors: implications for brain diseases.
Bordi F; Ugolini A
Prog Neurobiol; 1999 Sep; 59(1):55-79. PubMed ID: 10416961
[TBL] [Abstract][Full Text] [Related]
6. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective.
Su LD; Wang N; Han J; Shen Y
Neuroscientist; 2022 Oct; 28(5):453-468. PubMed ID: 34088252
[TBL] [Abstract][Full Text] [Related]
7. Nociception modulation by supraspinal group III metabotropic glutamate receptors.
Palazzo E; Marabese I; Luongo L; Guida F; de Novellis V; Maione S
J Neurochem; 2017 May; 141(4):507-519. PubMed ID: 27363363
[TBL] [Abstract][Full Text] [Related]
8. Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond.
Palazzo E; Marabese I; de Novellis V; Rossi F; Maione S
Eur J Neurosci; 2014 Feb; 39(3):444-54. PubMed ID: 24494684
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic Glutamate Receptors in Central Nervous System Diseases.
Golubeva AV; Moloney RD; O'Connor RM; Dinan TG; Cryan JF
Curr Drug Targets; 2016; 17(5):538-616. PubMed ID: 25777273
[TBL] [Abstract][Full Text] [Related]
10. A Review of Molecular Imaging of Glutamate Receptors.
Kim JH; Marton J; Ametamey SM; Cumming P
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081223
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamatergic receptors and their ligands in drug addiction.
Pomierny-Chamioło L; Rup K; Pomierny B; Niedzielska E; Kalivas PW; Filip M
Pharmacol Ther; 2014 Jun; 142(3):281-305. PubMed ID: 24362085
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Chronic Pain by Metabotropic Glutamate Receptors.
Chiechio S
Adv Pharmacol; 2016; 75():63-89. PubMed ID: 26920009
[TBL] [Abstract][Full Text] [Related]
13. Glutamate in CNS disorders as a target for drug development: an update.
Parsons CG; Danysz W; Quack G
Drug News Perspect; 1998 Nov; 11(9):523-69. PubMed ID: 15616669
[TBL] [Abstract][Full Text] [Related]
14. The Role of Glutamate Receptors in Epilepsy.
Chen TS; Huang TH; Lai MC; Huang CW
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979762
[TBL] [Abstract][Full Text] [Related]
15. Role of metabotropic glutamate receptors in the control of neuroendocrine function.
Durand D; Pampillo M; Caruso C; Lasaga M
Neuropharmacology; 2008 Sep; 55(4):577-83. PubMed ID: 18616955
[TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.
Ritzén A; Mathiesen JM; Thomsen C
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):202-13. PubMed ID: 16176554
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptors: a review on prospectives and therapeutic aspects.
Vaidya A; Jain S; Jain AK; Agrawal A; Kashaw SK; Jain SK; Agrawal RK
Mini Rev Med Chem; 2013 Nov; 13(13):1967-81. PubMed ID: 22530579
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
